 Sylvie Kandel
Concepts (156)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cytochrome P-450 Enzyme System | 7 | 2024 | 155 | 2.120 |
Why?
| | Cytochrome P-450 CYP3A | 7 | 2024 | 88 | 2.040 |
Why?
| | Cytochrome P-450 CYP3A Inhibitors | 3 | 2024 | 18 | 1.110 |
Why?
| | Dehydroepiandrosterone Sulfate | 2 | 2023 | 46 | 0.910 |
Why?
| | Raloxifene Hydrochloride | 1 | 2024 | 15 | 0.900 |
Why?
| | Ciprofloxacin | 1 | 2024 | 29 | 0.890 |
Why?
| | Pseudomonas aeruginosa | 2 | 2024 | 352 | 0.890 |
Why?
| | Nevirapine | 1 | 2023 | 17 | 0.850 |
Why?
| | Deuterium | 1 | 2023 | 99 | 0.810 |
Why?
| | Quinolones | 1 | 2024 | 137 | 0.780 |
Why?
| | Aminophenols | 1 | 2024 | 156 | 0.770 |
Why?
| | Lopinavir | 1 | 2021 | 30 | 0.710 |
Why?
| | Ritonavir | 1 | 2021 | 74 | 0.680 |
Why?
| | Anti-Retroviral Agents | 1 | 2021 | 233 | 0.610 |
Why?
| | Cyclopentanes | 2 | 2007 | 19 | 0.520 |
Why?
| | Acetates | 2 | 2007 | 99 | 0.500 |
Why?
| | Cytochromes b5 | 1 | 2014 | 2 | 0.460 |
Why?
| | NADPH-Ferrihemoprotein Reductase | 1 | 2014 | 11 | 0.450 |
Why?
| | Chemical and Drug Induced Liver Injury | 3 | 2023 | 136 | 0.450 |
Why?
| | Testosterone | 1 | 2017 | 401 | 0.420 |
Why?
| | Pharmaceutical Preparations | 1 | 2014 | 179 | 0.390 |
Why?
| | Arabidopsis Proteins | 2 | 2008 | 75 | 0.330 |
Why?
| | Oxylipins | 2 | 2007 | 40 | 0.330 |
Why?
| | Arabidopsis | 2 | 2008 | 95 | 0.330 |
Why?
| | Fatty Acids | 4 | 2022 | 442 | 0.310 |
Why?
| | Dicarboxylic Acids | 1 | 2007 | 8 | 0.280 |
Why?
| | Naphthalenes | 2 | 2024 | 60 | 0.270 |
Why?
| | Molecular Structure | 3 | 2023 | 489 | 0.240 |
Why?
| | Liver | 4 | 2023 | 1940 | 0.240 |
Why?
| | Acetaminophen | 2 | 2018 | 266 | 0.230 |
Why?
| | Clobetasol | 1 | 2024 | 7 | 0.230 |
Why?
| | Plant Proteins | 1 | 2005 | 113 | 0.230 |
Why?
| | HIV Reverse Transcriptase | 1 | 2023 | 31 | 0.210 |
Why?
| | Hydroxylation | 2 | 2017 | 39 | 0.210 |
Why?
| | Reverse Transcriptase Inhibitors | 1 | 2023 | 84 | 0.200 |
Why?
| | Cystic Fibrosis | 2 | 2024 | 1108 | 0.200 |
Why?
| | Microsomes, Liver | 2 | 2024 | 86 | 0.190 |
Why?
| | Aloe | 1 | 2022 | 2 | 0.190 |
Why?
| | Kinetics | 3 | 2022 | 1664 | 0.190 |
Why?
| | Hydroxyeicosatetraenoic Acids | 1 | 2022 | 43 | 0.190 |
Why?
| | Fluoresceins | 1 | 2021 | 47 | 0.180 |
Why?
| | Heme | 2 | 2023 | 78 | 0.180 |
Why?
| | Molecular Docking Simulation | 2 | 2022 | 113 | 0.180 |
Why?
| | Fluorocarbons | 1 | 2023 | 117 | 0.170 |
Why?
| | Drug Evaluation, Preclinical | 1 | 2021 | 184 | 0.170 |
Why?
| | Molecular Conformation | 1 | 2021 | 145 | 0.170 |
Why?
| | Drug Combinations | 1 | 2021 | 343 | 0.160 |
Why?
| | Iron | 2 | 2023 | 312 | 0.160 |
Why?
| | Glutathione | 2 | 2018 | 356 | 0.160 |
Why?
| | Chromatography, High Pressure Liquid | 4 | 2017 | 597 | 0.150 |
Why?
| | Premature Birth | 1 | 2023 | 331 | 0.150 |
Why?
| | Microsomes | 3 | 2008 | 33 | 0.150 |
Why?
| | Biological Products | 1 | 2022 | 215 | 0.150 |
Why?
| | Acetylglucosamine | 1 | 2018 | 13 | 0.150 |
Why?
| | Bacterial Proteins | 1 | 2024 | 873 | 0.140 |
Why?
| | N-Acetylglucosaminyltransferases | 1 | 2018 | 22 | 0.140 |
Why?
| | Protective Agents | 1 | 2018 | 41 | 0.140 |
Why?
| | Berberis | 1 | 2017 | 1 | 0.140 |
Why?
| | Hydrastis | 1 | 2017 | 3 | 0.140 |
Why?
| | Berberine | 1 | 2017 | 6 | 0.140 |
Why?
| | Biotransformation | 1 | 2017 | 65 | 0.140 |
Why?
| | Stereoisomerism | 1 | 2017 | 96 | 0.140 |
Why?
| | Cloning, Molecular | 3 | 2008 | 534 | 0.140 |
Why?
| | Oxidation-Reduction | 1 | 2021 | 1059 | 0.130 |
Why?
| | Hepatocytes | 1 | 2018 | 220 | 0.130 |
Why?
| | Hypolipidemic Agents | 1 | 2017 | 91 | 0.130 |
Why?
| | Anti-HIV Agents | 1 | 2023 | 775 | 0.130 |
Why?
| | Blotting, Northern | 2 | 2007 | 200 | 0.130 |
Why?
| | Substrate Specificity | 2 | 2007 | 371 | 0.120 |
Why?
| | Plant Extracts | 1 | 2017 | 202 | 0.120 |
Why?
| | Sulfolobus acidocaldarius | 1 | 2015 | 4 | 0.120 |
Why?
| | Humans | 11 | 2024 | 136765 | 0.120 |
Why?
| | HIV-1 | 1 | 2021 | 863 | 0.110 |
Why?
| | Archaeal Proteins | 1 | 2015 | 50 | 0.110 |
Why?
| | Protein Binding | 2 | 2018 | 2216 | 0.110 |
Why?
| | Anti-Bacterial Agents | 1 | 2024 | 1797 | 0.110 |
Why?
| | Serum Albumin | 1 | 2014 | 150 | 0.110 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2014 | 150 | 0.110 |
Why?
| | Dietary Supplements | 1 | 2017 | 559 | 0.100 |
Why?
| | Protein Isoforms | 1 | 2014 | 403 | 0.100 |
Why?
| | Fetus | 1 | 2017 | 806 | 0.100 |
Why?
| | Receptors, Progesterone | 1 | 2014 | 349 | 0.100 |
Why?
| | Animals | 4 | 2023 | 36847 | 0.080 |
Why?
| | Models, Molecular | 1 | 2015 | 1570 | 0.080 |
Why?
| | Infant, Newborn | 1 | 2021 | 6032 | 0.080 |
Why?
| | Epoxy Compounds | 1 | 2008 | 33 | 0.080 |
Why?
| | Biocatalysis | 1 | 2008 | 56 | 0.070 |
Why?
| | Hypoglycemic Agents | 1 | 2017 | 1283 | 0.070 |
Why?
| | Catalysis | 1 | 2007 | 307 | 0.060 |
Why?
| | DNA Primers | 1 | 2007 | 514 | 0.060 |
Why?
| | HIV Infections | 1 | 2021 | 2828 | 0.060 |
Why?
| | Biomarkers | 1 | 2017 | 4144 | 0.060 |
Why?
| | Antiviral Agents | 2 | 2022 | 739 | 0.060 |
Why?
| | Lauric Acids | 1 | 2005 | 4 | 0.060 |
Why?
| | Chromatography, Thin Layer | 1 | 2005 | 26 | 0.060 |
Why?
| | Phenobarbital | 1 | 2005 | 19 | 0.060 |
Why?
| | Stearic Acids | 1 | 2005 | 15 | 0.060 |
Why?
| | Triticum | 1 | 2005 | 17 | 0.060 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 975 | 0.060 |
Why?
| | Gas Chromatography-Mass Spectrometry | 1 | 2005 | 132 | 0.060 |
Why?
| | Gene Library | 1 | 2005 | 116 | 0.060 |
Why?
| | Genome, Plant | 1 | 2005 | 54 | 0.060 |
Why?
| | DNA, Complementary | 1 | 2005 | 271 | 0.060 |
Why?
| | Aryl Hydrocarbon Hydroxylases | 1 | 2024 | 48 | 0.060 |
Why?
| | Models, Chemical | 1 | 2005 | 263 | 0.050 |
Why?
| | Base Sequence | 1 | 2007 | 2179 | 0.050 |
Why?
| | Dehydroepiandrosterone | 1 | 2023 | 51 | 0.050 |
Why?
| | Tretinoin | 1 | 2023 | 123 | 0.050 |
Why?
| | Adult | 2 | 2023 | 37631 | 0.050 |
Why?
| | Arachidonic Acid | 1 | 2022 | 120 | 0.050 |
Why?
| | Protease Inhibitors | 1 | 2022 | 107 | 0.050 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2005 | 2052 | 0.040 |
Why?
| | High-Throughput Screening Assays | 1 | 2021 | 158 | 0.040 |
Why?
| | Vasodilator Agents | 1 | 2022 | 331 | 0.040 |
Why?
| | Fluorescent Dyes | 1 | 2021 | 317 | 0.040 |
Why?
| | Pseudomonas Infections | 1 | 2022 | 225 | 0.040 |
Why?
| | Birth Weight | 1 | 2023 | 514 | 0.040 |
Why?
| | Water | 1 | 2023 | 457 | 0.040 |
Why?
| | Acylation | 1 | 2018 | 30 | 0.040 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 1 | 2018 | 162 | 0.040 |
Why?
| | Pharmacopoeias as Topic | 1 | 2017 | 2 | 0.040 |
Why?
| | Food Inspection | 1 | 2017 | 2 | 0.040 |
Why?
| | Food Quality | 1 | 2017 | 10 | 0.030 |
Why?
| | Food Labeling | 1 | 2017 | 14 | 0.030 |
Why?
| | Capsules | 1 | 2017 | 38 | 0.030 |
Why?
| | Mice, Inbred C57BL | 2 | 2018 | 5749 | 0.030 |
Why?
| | Gene Expression | 2 | 2015 | 1500 | 0.030 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 1 | 2017 | 180 | 0.030 |
Why?
| | Costs and Cost Analysis | 1 | 2017 | 206 | 0.030 |
Why?
| | Male | 3 | 2018 | 67311 | 0.030 |
Why?
| | Peptide Mapping | 1 | 2015 | 64 | 0.030 |
Why?
| | Time Factors | 1 | 2005 | 6808 | 0.030 |
Why?
| | Amino Acid Motifs | 1 | 2015 | 225 | 0.030 |
Why?
| | Protein Stability | 1 | 2015 | 176 | 0.030 |
Why?
| | Tandem Mass Spectrometry | 1 | 2017 | 532 | 0.030 |
Why?
| | Catalytic Domain | 1 | 2015 | 207 | 0.030 |
Why?
| | Protein Structure, Secondary | 1 | 2015 | 374 | 0.030 |
Why?
| | Imidazoles | 1 | 2015 | 238 | 0.030 |
Why?
| | Pandemics | 1 | 2022 | 1612 | 0.030 |
Why?
| | Crystallography, X-Ray | 1 | 2015 | 476 | 0.030 |
Why?
| | Internet | 1 | 2017 | 647 | 0.020 |
Why?
| | Ligands | 1 | 2015 | 661 | 0.020 |
Why?
| | Nuclear Magnetic Resonance, Biomolecular | 1 | 2015 | 340 | 0.020 |
Why?
| | Protein Structure, Tertiary | 1 | 2015 | 860 | 0.020 |
Why?
| | Recombinant Proteins | 1 | 2015 | 1350 | 0.020 |
Why?
| | Enzyme Inhibitors | 1 | 2015 | 839 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2018 | 3008 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2018 | 4191 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2015 | 2894 | 0.020 |
Why?
| | Pregnancy | 1 | 2023 | 6726 | 0.020 |
Why?
| | Prospective Studies | 1 | 2022 | 7572 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2017 | 3265 | 0.020 |
Why?
| | Hydrolysis | 1 | 2008 | 176 | 0.020 |
Why?
| | Cytosol | 1 | 2008 | 226 | 0.020 |
Why?
| | United States | 1 | 2017 | 14690 | 0.010 |
Why?
| | Female | 1 | 2023 | 72795 | 0.010 |
Why?
|
|
Kandel's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|